PYPD PolyPid | $3.68
+12.4% | 6/9/2025 | Target Raised by | HC Wainwright | Analyst B. Folkes | Buy -> Buy | $11.00 -> $13.00 | N/A | View details for HC Wainwright rating of PolyPid (NASDAQ:PYPD) on 6/9/2025 |
COYA Coya Therapeutics | $5.88
| 6/9/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $18.00 | Medium | View details for HC Wainwright rating of Coya Therapeutics (NASDAQ:COYA) on 6/9/2025 |
BWAY BrainsWay | $10.70
+2.4% | 6/9/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $16.00 | High | View details for HC Wainwright rating of BrainsWay (NASDAQ:BWAY) on 6/9/2025 |
PHAT Phathom Pharmaceuticals | $8.34
-6.5% | 6/9/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $20.00 | High | View details for HC Wainwright rating of Phathom Pharmaceuticals (NASDAQ:PHAT) on 6/9/2025 |
HRTX Heron Therapeutics | $2.10
-0.2% | 6/9/2025 | Initiated by | HC Wainwright | Analyst Brandon Folkes | Buy | $6.00 | High | View details for HC Wainwright rating of Heron Therapeutics (NASDAQ:HRTX) on 6/9/2025 |
BBIO BridgeBio Pharma | $39.64
+2.6% | 6/9/2025 | Target Raised by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $53.00 -> $56.00 | Low | View details for HC Wainwright rating of BridgeBio Pharma (NASDAQ:BBIO) on 6/9/2025 |
ANVS Annovis Bio | $3.15
-1.8% | 6/9/2025 | Target Lowered by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $30.00 -> $12.00 | Medium | View details for HC Wainwright rating of Annovis Bio (NYSE:ANVS) on 6/9/2025 |
ARVN Arvinas | $7.53
| 6/2/2025 | Target Set by | HC Wainwright | Analyst Andrew Fein | | $24.00 | Low | View details for HC Wainwright rating of Arvinas (NASDAQ:ARVN) on 6/2/2025 |
FUFU BitFuFu | $3.54
+0.6% | 6/6/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of BitFuFu (NASDAQ:FUFU) on 6/6/2025 |
BNTX BioNTech | $108.37
-0.1% | 6/5/2025 | Target Raised by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $134.00 -> $145.00 | Low | View details for HC Wainwright rating of BioNTech (NASDAQ:BNTX) on 6/5/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
PHIO Phio Pharmaceuticals | $2.93
-0.9% | 6/5/2025 | Initiated by | HC Wainwright | Analyst Joseph Pantginis | Buy | $14.00 | High | View details for HC Wainwright rating of Phio Pharmaceuticals (NASDAQ:PHIO) on 6/5/2025 |
MIST Milestone Pharmaceuticals | $1.74
+0.3% | 6/5/2025 | Initiated by | HC Wainwright | Analyst Brandon Folkes | Buy | $5.00 | High | View details for HC Wainwright rating of Milestone Pharmaceuticals (NASDAQ:MIST) on 6/5/2025 |
TIL Instil Bio | $35.91
+9.2% | 6/5/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $125.00 -> $125.00 | N/A | View details for HC Wainwright rating of Instil Bio (NASDAQ:TIL) on 6/5/2025 |
ATYR Atyr PHARMA | $5.21
-3.3% | 6/4/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $35.00 | High | View details for HC Wainwright rating of Atyr PHARMA (NASDAQ:ATYR) on 6/4/2025 |
IBRX ImmunityBio | $3.37
+6.8% | 6/4/2025 | Reiterated by | HC Wainwright | Analyst A. Maldonado | Buy -> Buy | $8.00 | High | View details for HC Wainwright rating of ImmunityBio (NASDAQ:IBRX) on 6/4/2025 |
IMMX Immix Biopharma | $2.44
+2.7% | 6/4/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $7.00 | Medium | View details for HC Wainwright rating of Immix Biopharma (NASDAQ:IMMX) on 6/4/2025 |
AKBA Akebia Therapeutics | $3.98
+0.1% | 6/4/2025 | Initiated by | HC Wainwright | Analyst Matthew Caufield | Buy | $8.00 | High | View details for HC Wainwright rating of Akebia Therapeutics (NASDAQ:AKBA) on 6/4/2025 |
ANAB AnaptysBio | $22.59
-4.7% | 6/4/2025 | Upgraded by | HC Wainwright | Analyst E. Bodnar | Neutral -> Buy | $22.00 -> $38.00 | High | View details for HC Wainwright rating of AnaptysBio (NASDAQ:ANAB) on 6/4/2025 |
AGEN Agenus | $5.68
-4.6% | 6/4/2025 | Upgraded by | HC Wainwright | Analyst Emily Bodnar | Neutral -> Buy | $25.00 | High | View details for HC Wainwright rating of Agenus (NASDAQ:AGEN) on 6/4/2025 |
ACTU Actuate Therapeutics | $8.81
-1.7% | 6/3/2025 | Target Raised by | HC Wainwright | Analyst S. Ramakanth | Buy | $20.00 | Low | View details for HC Wainwright rating of Actuate Therapeutics (NASDAQ:ACTU) on 6/3/2025 |
PTGX Protagonist Therapeutics | $55.18
+1.5% | 6/3/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $80.00 | Low | View details for HC Wainwright rating of Protagonist Therapeutics (NASDAQ:PTGX) on 6/3/2025 |
YTRA Yatra Online | $0.95
-0.4% | 6/3/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of Yatra Online (NASDAQ:YTRA) on 6/3/2025 |
APLD Applied Digital | $13.98
+0.9% | 6/3/2025 | Target Raised by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $7.00 -> $12.00 | Low | View details for HC Wainwright rating of Applied Digital (NASDAQ:APLD) on 6/3/2025 |
ANL Adlai Nortye | $1.75
+0.6% | 6/2/2025 | Downgraded by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Neutral | | High | View details for HC Wainwright rating of Adlai Nortye (NASDAQ:ANL) on 6/2/2025 |
IMCR Immunocore | $35.87
-3.7% | 6/2/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $100.00 | Low | View details for HC Wainwright rating of Immunocore (NASDAQ:IMCR) on 6/2/2025 |
VERA Vera Therapeutics | $21.79
-4.0% | 6/2/2025 | Reiterated by | HC Wainwright | Analyst A. He | Buy -> Buy | $75.00 -> $85.00 | High | View details for HC Wainwright rating of Vera Therapeutics (NASDAQ:VERA) on 6/2/2025 |
PYPD PolyPid | $3.68
+12.4% | 6/2/2025 | Upgraded by | HC Wainwright | Analyst Brandon Folkes | Buy | $11.00 | High | View details for HC Wainwright rating of PolyPid (NASDAQ:PYPD) on 6/2/2025 |
CRDL Cardiol Therapeutics | $1.42
+0.4% | 6/2/2025 | Initiated by | HC Wainwright | Analyst Brandon Folkes | Buy | $9.00 | High | View details for HC Wainwright rating of Cardiol Therapeutics (NASDAQ:CRDL) on 6/2/2025 |
SENS Senseonics | $0.53
+0.2% | 6/2/2025 | Target Set by | HC Wainwright | Analyst Sean Lee | Buy | $1.10 | Low | View details for HC Wainwright rating of Senseonics (NYSE:SENS) on 6/2/2025 |
AVTX Avalo Therapeutics | $4.46
+8.7% | 6/2/2025 | Upgraded by | HC Wainwright | Analyst Mitchell Kapoor | Hold -> Buy | $15.00 | High | View details for HC Wainwright rating of Avalo Therapeutics (NASDAQ:AVTX) on 6/2/2025 |
VRNA Verona Pharma | $84.03
-0.4% | 6/2/2025 | Target Raised by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $85.00 -> $90.00 | High | View details for HC Wainwright rating of Verona Pharma (NASDAQ:VRNA) on 6/2/2025 |
GEVO Gevo | $1.17
+0.4% | 5/30/2025 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $14.00 | High | View details for HC Wainwright rating of Gevo (NASDAQ:GEVO) on 5/30/2025 |
ICCM IceCure Medical | $1.03
+1.5% | 5/29/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $2.50 | Low | View details for HC Wainwright rating of IceCure Medical (NASDAQ:ICCM) on 5/29/2025 |
EYPT EyePoint Pharmaceuticals | $8.80
-1.6% | 5/29/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $22.00 | Medium | View details for HC Wainwright rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 5/29/2025 |
OCUL Ocular Therapeutix | $8.71
-3.5% | 5/29/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $15.00 | Medium | View details for HC Wainwright rating of Ocular Therapeutix (NASDAQ:OCUL) on 5/29/2025 |
LPCN Lipocine | $3.31
+4.4% | 5/29/2025 | Upgraded by | HC Wainwright | Analyst Yi Chen | Strong-Buy | $8.00 | Low | View details for HC Wainwright rating of Lipocine (NASDAQ:LPCN) on 5/29/2025 |
QURE uniQure | $16.58
-4.0% | 5/29/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $70.00 | Medium | View details for HC Wainwright rating of uniQure (NASDAQ:QURE) on 5/29/2025 |
PEPG PepGen | $1.49
-0.7% | 5/29/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $14.00 -> $8.00 | High | View details for HC Wainwright rating of PepGen (NASDAQ:PEPG) on 5/29/2025 |
SVRA Savara | $2.34
-4.3% | 5/29/2025 | Downgraded by | HC Wainwright | Analyst Andrew Fein | Buy -> Neutral | $6.00 -> $2.00 | High | View details for HC Wainwright rating of Savara (NASDAQ:SVRA) on 5/29/2025 |
HALO Halozyme Therapeutics | $54.74
+0.9% | 5/29/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $72.00 | Low | View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 5/29/2025 |
Trump Makes Major Crypto Announcement (Ad) Pay close attention to what I'm about to share…
Most investors think Trump's pro-crypto policies will lift all boats equally. They're wrong.
One project stands to benefit more than any other – not by accident, but seemingly by design.
 Click Here to Discover our #1 crypto for the Trump Presidency Bull Run now! |
NTLA Intellia Therapeutics | $8.11
+0.2% | 5/29/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $30.00 | High | View details for HC Wainwright rating of Intellia Therapeutics (NASDAQ:NTLA) on 5/29/2025 |
DMAC DiaMedica Therapeutics | $4.16
+0.5% | 5/29/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of DiaMedica Therapeutics (NASDAQ:DMAC) on 5/29/2025 |
ETON Eton Pharmaceuticals | $16.39
-2.7% | 5/29/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $33.00 -> $35.00 | High | View details for HC Wainwright rating of Eton Pharmaceuticals (NASDAQ:ETON) on 5/29/2025 |
IVVD Invivyd | $0.95
-4.5% | 5/28/2025 | Target Lowered by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $10.00 -> $5.00 | Medium | View details for HC Wainwright rating of Invivyd (NASDAQ:IVVD) on 5/28/2025 |
YTRA Yatra Online | $0.95
-0.4% | 5/28/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $3.00 | High | View details for HC Wainwright rating of Yatra Online (NASDAQ:YTRA) on 5/28/2025 |
NPCE NeuroPace | $13.02
-1.0% | 5/28/2025 | Initiated by | HC Wainwright | Analyst Yi Chen | Buy | $18.00 | Medium | View details for HC Wainwright rating of NeuroPace (NASDAQ:NPCE) on 5/28/2025 |
AURA Aura Biosciences | $6.23
-4.2% | 5/28/2025 | Upgraded by | HC Wainwright | Analyst Andres Maldonado | Buy | $22.00 | Low | View details for HC Wainwright rating of Aura Biosciences (NASDAQ:AURA) on 5/28/2025 |
XOMA XOMA | $25.22
-0.1% | 5/28/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $104.00 | Low | View details for HC Wainwright rating of XOMA (NASDAQ:XOMA) on 5/28/2025 |
TRVI Trevi Therapeutics | $6.45
-8.6% | 5/28/2025 | Initiated by | HC Wainwright | Analyst Brandon Folkes | Buy -> Buy | $21.00 | Medium | View details for HC Wainwright rating of Trevi Therapeutics (NASDAQ:TRVI) on 5/28/2025 |
BLRX BioLineRx | $6.16
+7.2% | 5/28/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | | Medium | View details for HC Wainwright rating of BioLineRx (NASDAQ:BLRX) on 5/28/2025 |
ROIV Roivant Sciences | $11.02
-1.9% | 5/28/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $18.00 | High | View details for HC Wainwright rating of Roivant Sciences (NASDAQ:ROIV) on 5/28/2025 |
FNV Franco-Nevada | $167.46
+0.2% | 5/28/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $180.00 -> $195.00 | Low | View details for HC Wainwright rating of Franco-Nevada (NYSE:FNV) on 5/28/2025 |
LQDA Liquidia | $18.20
+0.3% | 5/28/2025 | Target Raised by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $29.00 -> $35.00 | High | View details for HC Wainwright rating of Liquidia (NASDAQ:LQDA) on 5/28/2025 |
VIGL Vigil Neuroscience | $7.89
+0.1% | 5/27/2025 | Downgraded by | HC Wainwright | Analyst Andrew Fein | Buy -> Neutral | $14.00 -> $8.00 | Low | View details for HC Wainwright rating of Vigil Neuroscience (NASDAQ:VIGL) on 5/27/2025 |
UNCY Unicycive Therapeutics | $1.00
+32.6% | 5/27/2025 | Upgraded by | HC Wainwright | Analyst Swayampakula Ramakanth | Strong-Buy | $9.00 | High | View details for HC Wainwright rating of Unicycive Therapeutics (NASDAQ:UNCY) on 5/27/2025 |
TARS Tarsus Pharmaceuticals | $43.67
-0.6% | 5/27/2025 | Upgraded by | HC Wainwright | Analyst Matthew Caufield | Buy | $72.00 | High | View details for HC Wainwright rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 5/27/2025 |
UBX Unity Biotechnology | $0.70
+2.2% | 5/27/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Neutral | $4.00 -> $2.00 | High | View details for HC Wainwright rating of Unity Biotechnology (NASDAQ:UBX) on 5/27/2025 |
CGTX Cognition Therapeutics | $0.30
+1.9% | 5/27/2025 | Target Lowered by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $5.00 -> $3.00 | High | View details for HC Wainwright rating of Cognition Therapeutics (NASDAQ:CGTX) on 5/27/2025 |
KYTX Kyverna Therapeutics | $3.27
-3.7% | 5/27/2025 | Upgraded by | HC Wainwright | Analyst Mitchell Kapoor | Neutral -> Buy | $4.00 -> $5.00 | High | View details for HC Wainwright rating of Kyverna Therapeutics (NASDAQ:KYTX) on 5/27/2025 |
OVID Ovid Therapeutics | $0.31
-2.4% | 5/27/2025 | Target Lowered by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $2.00 -> $1.50 | Medium | View details for HC Wainwright rating of Ovid Therapeutics (NASDAQ:OVID) on 5/27/2025 |
PRTA Prothena | $5.06
-6.5% | 5/27/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $30.00 -> $14.00 | High | View details for HC Wainwright rating of Prothena (NASDAQ:PRTA) on 5/27/2025 |
CLSD Clearside Biomedical | $0.76
-3.9% | 5/23/2025 | Target Lowered by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $6.00 -> $5.00 | Medium | View details for HC Wainwright rating of Clearside Biomedical (NASDAQ:CLSD) on 5/23/2025 |
USAU U.S. Gold | $13.39
-5.1% | 5/23/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $14.00 -> $15.00 | Medium | View details for HC Wainwright rating of U.S. Gold (NASDAQ:USAU) on 5/23/2025 |
DCTH Delcath Systems | $16.08
-1.8% | 5/23/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $24.00 -> $29.00 | Medium | View details for HC Wainwright rating of Delcath Systems (NASDAQ:DCTH) on 5/23/2025 |
KALA KALA BIO | $4.12
-0.5% | 5/23/2025 | Target Lowered by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $15.00 -> $12.00 | Low | View details for HC Wainwright rating of KALA BIO (NASDAQ:KALA) on 5/23/2025 |
BNTX BioNTech | $108.37
-0.1% | 5/22/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $134.00 -> $134.00 | Low | View details for HC Wainwright rating of BioNTech (NASDAQ:BNTX) on 5/22/2025 |
AXSM Axsome Therapeutics | $110.92
-0.9% | 5/22/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $180.00 -> $180.00 | Low | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 5/22/2025 |
URGN UroGen Pharma | $7.02
-4.8% | 5/22/2025 | Downgraded by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Neutral | | Medium | View details for HC Wainwright rating of UroGen Pharma (NASDAQ:URGN) on 5/22/2025 |
MDWD MediWound | $21.81
+1.0% | 5/22/2025 | Target Set by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $25.00 -> $31.00 | Medium | View details for HC Wainwright rating of MediWound (NASDAQ:MDWD) on 5/22/2025 |
SRPT Sarepta Therapeutics | $39.95
-7.1% | 5/22/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Neutral -> Neutral | $40.00 -> $40.00 | Medium | View details for HC Wainwright rating of Sarepta Therapeutics (NASDAQ:SRPT) on 5/22/2025 |
TIL Instil Bio | $35.91
+9.2% | 5/22/2025 | Target Lowered by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $110.00 -> $105.00 | N/A | View details for HC Wainwright rating of Instil Bio (NASDAQ:TIL) on 5/22/2025 |
RAPT RAPT Therapeutics | $1.14
-3.0% | 5/22/2025 | Upgraded by | HC Wainwright | Analyst R. Selvaraju | Strong-Buy | $6.00 | High | View details for HC Wainwright rating of RAPT Therapeutics (NASDAQ:RAPT) on 5/22/2025 |
GLXY Galaxy Digital | $20.59
+3.1% | 5/16/2025 | Upgraded by | HC Wainwright | Analyst M. Colonnese | Strong-Buy | | High | View details for HC Wainwright rating of Galaxy Digital (NASDAQ:GLXY) on 5/16/2025 |
IDN Intellicheck | $6.11
+2.9% | 5/21/2025 | Target Set by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $4.00 -> $6.00 | High | View details for HC Wainwright rating of Intellicheck (NYSE:IDN) on 5/21/2025 |
TRNS Transcat | $77.54
-0.6% | 5/21/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $106.00 -> $116.00 | High | View details for HC Wainwright rating of Transcat (NASDAQ:TRNS) on 5/21/2025 |
DTIL Precision BioSciences | $5.30
-3.6% | 5/21/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $60.00 -> $60.00 | High | View details for HC Wainwright rating of Precision BioSciences (NASDAQ:DTIL) on 5/21/2025 |
ANY Sphere 3D | $0.78
+2.0% | 5/21/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $3.00 -> $3.00 | Medium | View details for HC Wainwright rating of Sphere 3D (NASDAQ:ANY) on 5/21/2025 |
ONCY Oncolytics Biotech | $0.39
+7.2% | 5/21/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $5.00 -> $5.00 | High | View details for HC Wainwright rating of Oncolytics Biotech (NASDAQ:ONCY) on 5/21/2025 |
COGT Cogent Biosciences | $6.60
-2.9% | 5/20/2025 | Target Lowered by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $14.00 -> $12.00 | High | View details for HC Wainwright rating of Cogent Biosciences (NASDAQ:COGT) on 5/20/2025 |
TMC TMC the metals | $4.40
+7.2% | 5/20/2025 | Initiated by | HC Wainwright | Analyst Heiko Ihle | Buy | $5.50 | High | View details for HC Wainwright rating of TMC the metals (NASDAQ:TMC) on 5/20/2025 |
QSI Quantum-Si | $1.72
-1.4% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $5.50 | High | View details for HC Wainwright rating of Quantum-Si (NASDAQ:QSI) on 5/19/2025 |
TRDA Entrada Therapeutics | $8.17
-1.9% | 5/20/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $20.00 -> $20.00 | High | View details for HC Wainwright rating of Entrada Therapeutics (NASDAQ:TRDA) on 5/20/2025 |
FENC Fennec Pharmaceuticals | $8.28
-1.8% | 5/20/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $13.00 -> $13.00 | High | View details for HC Wainwright rating of Fennec Pharmaceuticals (NASDAQ:FENC) on 5/20/2025 |
IONS Ionis Pharmaceuticals | $36.38
+3.1% | 5/20/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $50.00 -> $50.00 | Medium | View details for HC Wainwright rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 5/20/2025 |
CRSP CRISPR Therapeutics | $41.14
-1.7% | 5/20/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $65.00 -> $65.00 | Low | View details for HC Wainwright rating of CRISPR Therapeutics (NASDAQ:CRSP) on 5/20/2025 |
NTLA Intellia Therapeutics | $8.11
+0.2% | 5/20/2025 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $30.00 -> $30.00 | High | View details for HC Wainwright rating of Intellia Therapeutics (NASDAQ:NTLA) on 5/20/2025 |
PRME Prime Medicine | $1.68
-0.9% | 5/20/2025 | Downgraded by | HC Wainwright | Analyst Arthur He | Buy -> Neutral | | High | View details for HC Wainwright rating of Prime Medicine (NYSE:PRME) on 5/20/2025 |
ARWR Arrowhead Pharmaceuticals | $16.51
-1.8% | 5/20/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $80.00 -> $80.00 | Medium | View details for HC Wainwright rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 5/20/2025 |
ATAI Atai Life Sciences | $2.22
-8.1% | 5/20/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of Atai Life Sciences (NASDAQ:ATAI) on 5/20/2025 |
FHTX Foghorn Therapeutics | $4.36
-2.2% | 5/14/2025 | Upgraded by | HC Wainwright | Analyst A. Fein | Strong-Buy | | High | View details for HC Wainwright rating of Foghorn Therapeutics (NASDAQ:FHTX) on 5/14/2025 |
A grave, grave error. (Ad) I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was.
Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.  Here’s the full story for you. |
ARMP Armata Pharmaceuticals | $1.97
-0.5% | 5/19/2025 | Target Raised by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $7.00 -> $9.00 | N/A | View details for HC Wainwright rating of Armata Pharmaceuticals (NYSEAMERICAN:ARMP) on 5/19/2025 |
BITF Bitfarms | $0.89
-0.8% | 5/14/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | | Medium | View details for HC Wainwright rating of Bitfarms (NASDAQ:BITF) on 5/14/2025 |
PHGE BiomX | $0.46
-38.3% | 5/16/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | | N/A | View details for HC Wainwright rating of BiomX (NYSEMKT:PHGE) on 5/16/2025 |
IOBT IO Biotech | $1.54
-4.1% | 5/14/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | | High | View details for HC Wainwright rating of IO Biotech (NASDAQ:IOBT) on 5/14/2025 |
LPTH LightPath Technologies | $2.93
-1.9% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $5.00 -> $5.00 | Low | View details for HC Wainwright rating of LightPath Technologies (NASDAQ:LPTH) on 5/19/2025 |
MIGI Mawson Infrastructure Group | $0.55
-2.9% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Neutral -> Neutral | | Low | View details for HC Wainwright rating of Mawson Infrastructure Group (NASDAQ:MIGI) on 5/19/2025 |
BTBT Bit Digital | $2.59
-2.5% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of Bit Digital (NASDAQ:BTBT) on 5/19/2025 |
PTGX Protagonist Therapeutics | $55.18
+1.5% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $80.00 -> $80.00 | High | View details for HC Wainwright rating of Protagonist Therapeutics (NASDAQ:PTGX) on 5/19/2025 |
ALDX Aldeyra Therapeutics | $2.63
-1.3% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Aldeyra Therapeutics (NASDAQ:ALDX) on 5/19/2025 |
OPTN OptiNose | $9.60
| 5/19/2025 | Reiterated by | HC Wainwright | Analyst M. Caufield | Neutral -> Neutral | $9.00 -> $9.00 | Low | View details for HC Wainwright rating of OptiNose (NASDAQ:OPTN) on 5/19/2025 |
CASI CASI Pharmaceuticals | $1.84
-1.2% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst Sean Lee | Buy -> Buy | $4.00 -> $4.00 | Low | View details for HC Wainwright rating of CASI Pharmaceuticals (NASDAQ:CASI) on 5/19/2025 |
RNXT RenovoRx | $1.40
+0.7% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst S. Ramakanth | Buy -> Buy | $3.00 -> $3.00 | High | View details for HC Wainwright rating of RenovoRx (NASDAQ:RNXT) on 5/19/2025 |
PYXS Pyxis Oncology | $1.34
-0.7% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $5.00 -> $5.00 | High | View details for HC Wainwright rating of Pyxis Oncology (NASDAQ:PYXS) on 5/19/2025 |
CELC Celcuity | $12.82
-1.8% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $27.00 -> $27.00 | Low | View details for HC Wainwright rating of Celcuity (NASDAQ:CELC) on 5/19/2025 |
MIRM Mirum Pharmaceuticals | $45.49
-1.9% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy | $73.00 | Low | View details for HC Wainwright rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 5/19/2025 |
ATYR Atyr PHARMA | $5.21
-3.3% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $35.00 -> $35.00 | Medium | View details for HC Wainwright rating of Atyr PHARMA (NASDAQ:ATYR) on 5/19/2025 |
BNTC Benitec Biopharma | $15.92
-0.5% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $28.00 -> $28.00 | High | View details for HC Wainwright rating of Benitec Biopharma (NASDAQ:BNTC) on 5/19/2025 |
CRIS Curis | $2.39
+0.6% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy | $17.00 | Medium | View details for HC Wainwright rating of Curis (NASDAQ:CRIS) on 5/19/2025 |
GANX Gain Therapeutics | $1.91
-0.5% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $8.00 -> $8.00 | High | View details for HC Wainwright rating of Gain Therapeutics (NASDAQ:GANX) on 5/19/2025 |
ACAD ACADIA Pharmaceuticals | $21.96
-0.1% | 5/19/2025 | Target Raised by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $27.00 -> $32.00 | Low | View details for HC Wainwright rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 5/19/2025 |
ASRT Assertio | $0.67
+0.8% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $3.50 -> $3.50 | Low | View details for HC Wainwright rating of Assertio (NASDAQ:ASRT) on 5/19/2025 |
VANI Vivani Medical | $1.15
-0.4% | 5/19/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $4.00 -> $4.00 | High | View details for HC Wainwright rating of Vivani Medical (NASDAQ:VANI) on 5/19/2025 |
YMAB Y-mAbs Therapeutics | $5.08
-3.6% | 5/19/2025 | Target Lowered by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $12.00 -> $11.00 | Medium | View details for HC Wainwright rating of Y-mAbs Therapeutics (NASDAQ:YMAB) on 5/19/2025 |
WYY WidePoint | $3.47
-1.2% | 5/16/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of WidePoint (NYSEAMERICAN:WYY) on 5/16/2025 |
REE REE Automotive | $0.80
+1.9% | 5/16/2025 | Downgraded by | HC Wainwright | Analyst A. Dayal | Buy -> Neutral | | High | View details for HC Wainwright rating of REE Automotive (NASDAQ:REE) on 5/16/2025 |
KSCP Knightscope | $6.22
-0.9% | 5/16/2025 | Reiterated by | HC Wainwright | Analyst S. Buck | Buy -> Buy | $12.00 -> $12.00 | High | View details for HC Wainwright rating of Knightscope (NASDAQ:KSCP) on 5/16/2025 |
WKSP Worksport | $3.37
+4.0% | 5/16/2025 | Reiterated by | HC Wainwright | Analyst S. Buck | Buy -> Buy | $11.50 -> $11.50 | Medium | View details for HC Wainwright rating of Worksport (NASDAQ:WKSP) on 5/16/2025 |
LGO Largo | $1.35
-1.1% | 5/16/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $3.90 -> $3.70 | High | View details for HC Wainwright rating of Largo (NYSE:LGO) on 5/16/2025 |
CVKD Cadrenal Therapeutics | $15.00
-0.7% | 5/16/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $32.00 -> $32.00 | Low | View details for HC Wainwright rating of Cadrenal Therapeutics (NASDAQ:CVKD) on 5/16/2025 |
ZBIO Zenas Biopharma | $11.44
+2.9% | 5/16/2025 | Reiterated by | HC Wainwright | Analyst M. Caufield | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for HC Wainwright rating of Zenas Biopharma (NASDAQ:ZBIO) on 5/16/2025 |
HURA TuHURA Biosciences | $2.84
+1.0% | 5/16/2025 | Reiterated by | HC Wainwright | Analyst R. Burns | Buy -> Buy | $12.00 -> $12.00 | Medium | View details for HC Wainwright rating of TuHURA Biosciences (NASDAQ:HURA) on 5/16/2025 |
BCAX Bicara Therapeutics | $11.30
-1.8% | 5/16/2025 | Target Lowered by | HC Wainwright | Analyst R. Burns | Buy -> Buy | $44.00 -> $41.00 | High | View details for HC Wainwright rating of Bicara Therapeutics (NASDAQ:BCAX) on 5/16/2025 |
ACOG Alpha Cognition | $9.00
-4.1% | 5/16/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $20.00 -> $20.00 | High | View details for HC Wainwright rating of Alpha Cognition (NASDAQ:ACOG) on 5/16/2025 |
LXEO Lexeo Therapeutics | $4.09
+5.4% | 5/16/2025 | Target Lowered by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $23.00 -> $15.00 | High | View details for HC Wainwright rating of Lexeo Therapeutics (NASDAQ:LXEO) on 5/16/2025 |
DEFT Defi Technologies | $3.36
+0.3% | 5/15/2025 | Target Raised by | HC Wainwright | Analyst Kevin Dede | Buy -> Buy | $4.50 -> $5.50 | Low | View details for HC Wainwright rating of Defi Technologies (NASDAQ:DEFT) on 5/15/2025 |
AQST Aquestive Therapeutics | $3.66
+2.7% | 5/15/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Aquestive Therapeutics (NASDAQ:AQST) on 5/15/2025 |
IREN Iris Energy | $10.11
+3.6% | 5/15/2025 | Target Lowered by | HC Wainwright | Analyst Mike Colonnese | Buy -> Buy | $22.00 -> $21.00 | Low | View details for HC Wainwright rating of Iris Energy (NASDAQ:IREN) on 5/15/2025 |
ASM Avino Silver & Gold Mines | $3.60
+0.7% | 5/15/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $2.20 -> $2.80 | High | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 5/15/2025 |
ASM Avino Silver & Gold Mines | $3.60
+2.4% | 5/15/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $2.20 -> $2.80 | High | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 5/15/2025 |
ADVM Adverum Biotechnologies | $2.86
+1.1% | 5/15/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $30.00 -> $30.00 | Low | View details for HC Wainwright rating of Adverum Biotechnologies (NASDAQ:ADVM) on 5/15/2025 |
CTMX CytomX Therapeutics | $2.83
+7.0% | 5/15/2025 | Upgraded by | HC Wainwright | Analyst Mitchell Kapoor | Neutral -> Buy | $5.00 -> $5.00 | High | View details for HC Wainwright rating of CytomX Therapeutics (NASDAQ:CTMX) on 5/15/2025 |
CALC CalciMedica | $1.77
+1.4% | 5/15/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $16.00 -> $16.00 | Low | View details for HC Wainwright rating of CalciMedica (NASDAQ:CALC) on 5/15/2025 |
ELVN Enliven Therapeutics | $20.13
-3.0% | 5/15/2025 | Target Raised by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $39.00 -> $40.00 | N/A | View details for HC Wainwright rating of Enliven Therapeutics (NASDAQ:ELVN) on 5/15/2025 |
BLTE Belite Bio | $61.04
+2.3% | 5/15/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $100.00 -> $100.00 | High | View details for HC Wainwright rating of Belite Bio (NASDAQ:BLTE) on 5/15/2025 |
SMTI Sanara MedTech | $29.20
-1.0% | 5/15/2025 | Target Raised by | HC Wainwright | Analyst Y. Chen | Buy -> Buy | $51.00 -> $53.00 | High | View details for HC Wainwright rating of Sanara MedTech (NASDAQ:SMTI) on 5/15/2025 |
ZNTL Zentalis Pharmaceuticals | $1.49
-2.3% | 5/15/2025 | Reiterated by | HC Wainwright | Analyst Andres Maldonado | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 5/15/2025 |
CTSO Cytosorbents | $1.05
-0.9% | 5/15/2025 | Reiterated by | HC Wainwright | Analyst Sean Lee | Neutral -> Neutral | $1.00 -> $1.00 | Low | View details for HC Wainwright rating of Cytosorbents (NASDAQ:CTSO) on 5/15/2025 |
HUMA Humacyte | $2.59
-0.2% | 5/14/2025 | Initiated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy | $4.00 | High | View details for HC Wainwright rating of Humacyte (NASDAQ:HUMA) on 5/14/2025 |
MOGO Mogo | $1.33
-1.9% | 5/14/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $4.00 -> $4.00 | Medium | View details for HC Wainwright rating of Mogo (NASDAQ:MOGO) on 5/14/2025 |
AVBP ArriVent BioPharma | $23.42
-0.4% | 5/14/2025 | Target Raised by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $39.00 -> $40.00 | Medium | View details for HC Wainwright rating of ArriVent BioPharma (NASDAQ:AVBP) on 5/14/2025 |
A grave, grave error. (Ad) I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was.
Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. |
STOK Stoke Therapeutics | $10.99
-1.4% | 5/14/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $47.00 -> $35.00 | Low | View details for HC Wainwright rating of Stoke Therapeutics (NASDAQ:STOK) on 5/14/2025 |
BNTX BioNTech | $108.37
-0.1% | 5/14/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $145.00 -> $134.00 | Medium | View details for HC Wainwright rating of BioNTech (NASDAQ:BNTX) on 5/14/2025 |
RVMD Revolution Medicines | $40.71
-0.9% | 5/14/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $73.00 -> $72.00 | Low | View details for HC Wainwright rating of Revolution Medicines (NASDAQ:RVMD) on 5/14/2025 |
SABS SAB Biotherapeutics | $1.83
+1.1% | 5/14/2025 | Initiated by | HC Wainwright | Analyst Emily Bodnar | Buy | $10.00 | High | View details for HC Wainwright rating of SAB Biotherapeutics (NASDAQ:SABS) on 5/14/2025 |
ACRS Aclaris Therapeutics | $1.51
-1.6% | 5/14/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $20.00 -> $16.00 | Medium | View details for HC Wainwright rating of Aclaris Therapeutics (NASDAQ:ACRS) on 5/14/2025 |
ITOS iTeos Therapeutics | $10.01
-1.6% | 5/14/2025 | Downgraded by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Neutral | | High | View details for HC Wainwright rating of iTeos Therapeutics (NASDAQ:ITOS) on 5/14/2025 |
EXK Endeavour Silver | $5.05
+12.4% | 5/14/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $7.25 -> $7.25 | High | View details for HC Wainwright rating of Endeavour Silver (NYSE:EXK) on 5/14/2025 |
ANNX Annexon | $2.53
-2.9% | 5/14/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $20.00 -> $14.00 | High | View details for HC Wainwright rating of Annexon (NASDAQ:ANNX) on 5/14/2025 |
BLNK Blink Charging | $0.92
+5.8% | 5/14/2025 | Target Lowered by | HC Wainwright | Analyst Sameer Joshi | Buy -> Buy | $8.00 -> $5.00 | High | View details for HC Wainwright rating of Blink Charging (NASDAQ:BLNK) on 5/14/2025 |
INUV Inuvo | $0.40
-0.3% | 5/13/2025 | Reiterated by | HC Wainwright | Analyst S. Buck | Buy -> Buy | $2.00 -> $2.00 | High | View details for HC Wainwright rating of Inuvo (NYSE:INUV) on 5/13/2025 |
GRYP Gryphon Digital Mining | $1.14
+2.3% | 5/13/2025 | Reiterated by | HC Wainwright | Analyst Kevin Dede | Neutral -> Neutral | | High | View details for HC Wainwright rating of Gryphon Digital Mining (NASDAQ:GRYP) on 5/13/2025 |
EU enCore Energy | $2.35
+9.6% | 5/13/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $2.75 -> $2.75 | Low | View details for HC Wainwright rating of enCore Energy (NASDAQ:EU) on 5/13/2025 |
PPTA Perpetua Resources | $17.21
-0.9% | 5/13/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $28.00 -> $27.50 | High | View details for HC Wainwright rating of Perpetua Resources (NASDAQ:PPTA) on 5/13/2025 |
XENE Xenon Pharmaceuticals | $30.95
-2.2% | 5/13/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $53.00 -> $53.00 | High | View details for HC Wainwright rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 5/13/2025 |
AGEN Agenus | $5.68
-4.6% | 5/13/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Neutral -> Neutral | | High | View details for HC Wainwright rating of Agenus (NASDAQ:AGEN) on 5/13/2025 |
ACHR Archer Aviation | $11.28
+10.7% | 5/13/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $12.50 -> $12.50 | High | View details for HC Wainwright rating of Archer Aviation (NYSE:ACHR) on 5/13/2025 |
FGEN FibroGen | $0.32
+1.8% | 5/13/2025 | Reiterated by | HC Wainwright | Analyst M. Keller | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of FibroGen (NASDAQ:FGEN) on 5/13/2025 |
EXOD Exodus Movement | $30.30
+5.0% | 5/13/2025 | Target Raised by | HC Wainwright | Analyst K. Dede | Buy -> Buy | $50.00 -> $65.00 | N/A | View details for HC Wainwright rating of Exodus Movement (NYSEAMERICAN:EXOD) on 5/13/2025 |
MLYS Mineralys Therapeutics | $15.92
-1.3% | 5/13/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $42.00 -> $42.00 | High | View details for HC Wainwright rating of Mineralys Therapeutics (NASDAQ:MLYS) on 5/13/2025 |
DNTH Dianthus Therapeutics | $18.42
-2.3% | 5/13/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $40.00 -> $40.00 | High | View details for HC Wainwright rating of Dianthus Therapeutics (NASDAQ:DNTH) on 5/13/2025 |
URGN UroGen Pharma | $7.02
-4.8% | 5/13/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $55.00 -> $55.00 | High | View details for HC Wainwright rating of UroGen Pharma (NASDAQ:URGN) on 5/13/2025 |
NGNE Neurogene | $19.73
-9.6% | 5/13/2025 | Target Lowered by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $50.00 -> $45.00 | High | View details for HC Wainwright rating of Neurogene (NASDAQ:NGNE) on 5/13/2025 |
BLFS BioLife Solutions | $24.26
+2.3% | 5/13/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $30.00 -> $30.00 | Low | View details for HC Wainwright rating of BioLife Solutions (NASDAQ:BLFS) on 5/13/2025 |
ATNM Actinium Pharmaceuticals | $1.85
+0.9% | 5/12/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $4.00 -> $4.00 | Low | View details for HC Wainwright rating of Actinium Pharmaceuticals (NYSE:ATNM) on 5/12/2025 |
IBRX ImmunityBio | $3.37
+6.8% | 5/12/2025 | Reiterated by | HC Wainwright | Analyst A. Maldonado | Buy -> Buy | $8.00 -> $8.00 | Medium | View details for HC Wainwright rating of ImmunityBio (NASDAQ:IBRX) on 5/12/2025 |
OCGN Ocugen | $1.10
+3.3% | 5/12/2025 | Target Lowered by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $8.00 -> $7.00 | Low | View details for HC Wainwright rating of Ocugen (NASDAQ:OCGN) on 5/12/2025 |
FUFU BitFuFu | $3.54
+0.6% | 5/12/2025 | Reiterated by | HC Wainwright | Analyst K. Dede | Buy -> Buy | $7.00 -> $7.00 | Low | View details for HC Wainwright rating of BitFuFu (NASDAQ:FUFU) on 5/12/2025 |
SOUN SoundHound AI | $10.11
0.0% | 5/12/2025 | Target Lowered by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $26.00 -> $18.00 | High | View details for HC Wainwright rating of SoundHound AI (NASDAQ:SOUN) on 5/12/2025 |
SRZN Surrozen | $8.38
-1.5% | 5/12/2025 | Reiterated by | HC Wainwright | Analyst M. Caufield | Buy -> Buy | $32.00 -> $32.00 | High | View details for HC Wainwright rating of Surrozen (NASDAQ:SRZN) on 5/12/2025 |
CMPS COMPASS Pathways | $4.69
-2.4% | 5/12/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $45.00 -> $45.00 | Medium | View details for HC Wainwright rating of COMPASS Pathways (NASDAQ:CMPS) on 5/12/2025 |
HROW Harrow | $30.41
+2.8% | 5/12/2025 | Target Raised by | HC Wainwright | Analyst Y. Chen | Buy -> Buy | $57.00 -> $60.00 | High | View details for HC Wainwright rating of Harrow (NASDAQ:HROW) on 5/12/2025 |
LQDA Liquidia | $18.20
+0.3% | 5/12/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $29.00 -> $29.00 | High | View details for HC Wainwright rating of Liquidia (NASDAQ:LQDA) on 5/12/2025 |
INSM Insmed | $71.34
-3.1% | 5/12/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $90.00 -> $90.00 | Low | View details for HC Wainwright rating of Insmed (NASDAQ:INSM) on 5/12/2025 |
RNA Avidity Biosciences | $32.09
-11.5% | 5/12/2025 | Target Lowered by | HC Wainwright | Analyst A. Ghosh | Buy -> Buy | $72.00 -> $68.00 | High | View details for HC Wainwright rating of Avidity Biosciences (NASDAQ:RNA) on 5/12/2025 |
GPCR Structure Therapeutics | $20.38
-3.5% | 5/12/2025 | Target Lowered by | HC Wainwright | Analyst A. Ghosh | Buy -> Buy | $80.00 -> $75.00 | High | View details for HC Wainwright rating of Structure Therapeutics (NASDAQ:GPCR) on 5/12/2025 |
MUX McEwen Mining | $9.59
+2.5% | 5/9/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $18.00 -> $15.50 | Low | View details for HC Wainwright rating of McEwen Mining (NYSE:MUX) on 5/9/2025 |
ALEC Alector | $1.41
-5.7% | 5/9/2025 | Target Raised by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $7.00 -> $10.00 | High | View details for HC Wainwright rating of Alector (NASDAQ:ALEC) on 5/9/2025 |
PRTA Prothena | $5.06
-6.5% | 5/9/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $48.00 -> $30.00 | Low | View details for HC Wainwright rating of Prothena (NASDAQ:PRTA) on 5/9/2025 |
PEPG PepGen | $1.49
-0.7% | 5/9/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $16.00 -> $14.00 | High | View details for HC Wainwright rating of PepGen (NASDAQ:PEPG) on 5/9/2025 |
GHRS GH Research | $13.18
+5.4% | 5/9/2025 | Reiterated by | HC Wainwright | Analyst Patrick Trucchio | Buy -> Buy | $40.00 -> $40.00 | Medium | View details for HC Wainwright rating of GH Research (NASDAQ:GHRS) on 5/9/2025 |
AMLX Amylyx Pharmaceuticals | $5.34
+0.2% | 5/9/2025 | Target Raised by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $12.00 -> $16.00 | Low | View details for HC Wainwright rating of Amylyx Pharmaceuticals (NASDAQ:AMLX) on 5/9/2025 |
DYN Dyne Therapeutics | $14.48
-1.5% | 5/9/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $46.00 -> $38.00 | Medium | View details for HC Wainwright rating of Dyne Therapeutics (NASDAQ:DYN) on 5/9/2025 |
VSTM Verastem | $6.16
-4.0% | 5/9/2025 | Target Raised by | HC Wainwright | Analyst Sean Lee | Buy -> Buy | $10.00 -> $14.00 | Medium | View details for HC Wainwright rating of Verastem (NASDAQ:VSTM) on 5/9/2025 |
CRDF Cardiff Oncology | $3.71
-4.5% | 5/9/2025 | Target Raised by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $17.00 -> $18.00 | Low | View details for HC Wainwright rating of Cardiff Oncology (NASDAQ:CRDF) on 5/9/2025 |
DPRO Draganfly | $3.16
+6.5% | 5/9/2025 | Target Lowered by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $7.00 -> $5.00 | Medium | View details for HC Wainwright rating of Draganfly (NASDAQ:DPRO) on 5/9/2025 |
AG First Majestic Silver | $8.45
+2.1% | 5/9/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $11.00 -> $11.50 | High | View details for HC Wainwright rating of First Majestic Silver (NYSE:AG) on 5/9/2025 |
UAMY United States Antimony | $3.02
-10.5% | 5/9/2025 | Target Raised by | HC Wainwright | Analyst H. Ihle | Buy -> Buy | $2.60 -> $4.50 | High | View details for HC Wainwright rating of United States Antimony (NYSE:UAMY) on 5/9/2025 |
UUUU Energy Fuels | $5.80
+6.0% | 5/9/2025 | Target Lowered by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $10.75 -> $10.00 | N/A | View details for HC Wainwright rating of Energy Fuels (NYSEAMERICAN:UUUU) on 5/9/2025 |
HUT Hut 8 | $18.43
-0.7% | 5/9/2025 | Reiterated by | HC Wainwright | Analyst Mike Colonnese | Buy -> Buy | $25.00 -> $25.00 | High | View details for HC Wainwright rating of Hut 8 (NASDAQ:HUT) on 5/9/2025 |
ALXO ALX Oncology | $0.61
+4.5% | 5/9/2025 | Target Lowered by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $5.00 -> $2.00 | High | View details for HC Wainwright rating of ALX Oncology (NASDAQ:ALXO) on 5/9/2025 |
A grave, grave error. (Ad) I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was.
Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. |
VOR Vor Biopharma | $0.22
-0.4% | 5/9/2025 | Reiterated by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Neutral | | High | View details for HC Wainwright rating of Vor Biopharma (NYSE:VOR) on 5/9/2025 |
IOVA Iovance Biotherapeutics | $2.19
+6.6% | 5/9/2025 | Target Lowered by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $32.00 -> $20.00 | N/A | View details for HC Wainwright rating of Iovance Biotherapeutics (NASDAQ:IOVA) on 5/9/2025 |
FEMY Femasys | $0.79
-0.8% | 5/9/2025 | Target Lowered by | HC Wainwright | Analyst Emily Bodnar | Buy -> Buy | $15.00 -> $12.00 | High | View details for HC Wainwright rating of Femasys (NASDAQ:FEMY) on 5/9/2025 |
SAND Sandstorm Gold | $9.18
-0.2% | 5/8/2025 | Target Raised by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $11.50 -> $11.75 | Medium | View details for HC Wainwright rating of Sandstorm Gold (NYSE:SAND) on 5/8/2025 |
LENZ LENZ Therapeutics | $30.16
-5.6% | 5/8/2025 | Reiterated by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $38.00 -> $38.00 | High | View details for HC Wainwright rating of LENZ Therapeutics (NASDAQ:LENZ) on 5/8/2025 |
KROS Keros Therapeutics | $14.32
-4.8% | 5/8/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $40.00 -> $25.00 | Medium | View details for HC Wainwright rating of Keros Therapeutics (NASDAQ:KROS) on 5/8/2025 |
ITRM Iterum Therapeutics | $0.98
+0.5% | 5/8/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy | $9.00 | High | View details for HC Wainwright rating of Iterum Therapeutics (NASDAQ:ITRM) on 5/8/2025 |
KRRO Korro Bio | $14.51
-0.6% | 5/8/2025 | Target Lowered by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $115.00 -> $100.00 | High | View details for HC Wainwright rating of Korro Bio (NASDAQ:KRRO) on 5/8/2025 |
CIFR Cipher Mining | $4.03
+3.2% | 5/6/2025 | Reiterated by | HC Wainwright | - | Buy -> Buy | | High | View details for HC Wainwright rating of Cipher Mining (NASDAQ:CIFR) on 5/6/2025 |
DNLI Denali Therapeutics | $14.73
+0.2% | 5/7/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $80.00 -> $32.00 | High | View details for HC Wainwright rating of Denali Therapeutics (NASDAQ:DNLI) on 5/7/2025 |
VNDA Vanda Pharmaceuticals | $4.68
+1.5% | 5/7/2025 | Reiterated by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $20.00 -> $20.00 | High | View details for HC Wainwright rating of Vanda Pharmaceuticals (NASDAQ:VNDA) on 5/7/2025 |
SRPT Sarepta Therapeutics | $39.95
-7.1% | 5/7/2025 | Target Lowered by | HC Wainwright | Analyst M. Kapoor | Neutral -> Neutral | $75.00 -> $40.00 | High | View details for HC Wainwright rating of Sarepta Therapeutics (NASDAQ:SRPT) on 5/7/2025 |
CRBP Corbus Pharmaceuticals | $9.03
-2.2% | 5/7/2025 | Target Lowered by | HC Wainwright | Analyst Andres Maldonado | Buy -> Buy | $50.00 -> $40.00 | High | View details for HC Wainwright rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 5/7/2025 |
AXSM Axsome Therapeutics | $110.92
-0.9% | 5/7/2025 | Target Lowered by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $200.00 -> $180.00 | Low | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 5/7/2025 |
TCRX TScan Therapeutics | $1.74
-3.6% | 5/7/2025 | Target Lowered by | HC Wainwright | Analyst Andres Maldonado | Buy -> Buy | $15.00 -> $10.00 | Low | View details for HC Wainwright rating of TScan Therapeutics (NASDAQ:TCRX) on 5/7/2025 |
PSNL Personalis | $5.35
+2.7% | 5/7/2025 | Target Raised by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $8.00 -> $9.00 | High | View details for HC Wainwright rating of Personalis (NASDAQ:PSNL) on 5/7/2025 |
KRYS Krystal Biotech | $137.09
+0.1% | 5/6/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $240.00 -> $240.00 | High | View details for HC Wainwright rating of Krystal Biotech (NASDAQ:KRYS) on 5/6/2025 |
ALKS Alkermes | $31.49
-0.7% | 5/2/2025 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | | Medium | View details for HC Wainwright rating of Alkermes (NASDAQ:ALKS) on 5/2/2025 |
IBRX ImmunityBio | $3.37
+6.8% | 5/5/2025 | Reiterated by | HC Wainwright | Analyst A. Maldonado | Buy -> Buy | | High | View details for HC Wainwright rating of ImmunityBio (NASDAQ:IBRX) on 5/5/2025 |
EKSO Ekso Bionics | $4.30
+0.6% | 5/6/2025 | Target Lowered by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $2,025.00 -> $900.00 | High | View details for HC Wainwright rating of Ekso Bionics (NASDAQ:EKSO) on 5/6/2025 |
CORT Corcept Therapeutics | $69.99
+0.6% | 5/6/2025 | Target Lowered by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $150.00 -> $145.00 | High | View details for HC Wainwright rating of Corcept Therapeutics (NASDAQ:CORT) on 5/6/2025 |
CLDX Celldex Therapeutics | $20.26
-5.1% | 5/6/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $80.00 -> $80.00 | High | View details for HC Wainwright rating of Celldex Therapeutics (NASDAQ:CLDX) on 5/6/2025 |
BMEA Biomea Fusion | $2.38
-4.4% | 5/6/2025 | Target Lowered by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $40.00 -> $18.00 | High | View details for HC Wainwright rating of Biomea Fusion (NASDAQ:BMEA) on 5/6/2025 |
BCRX BioCryst Pharmaceuticals | $11.10
+0.5% | 5/6/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $30.00 -> $30.00 | High | View details for HC Wainwright rating of BioCryst Pharmaceuticals (NASDAQ:BCRX) on 5/6/2025 |
VERA Vera Therapeutics | $21.79
-4.0% | 5/5/2025 | Initiated by | HC Wainwright | Analyst Arthur He | Buy | $75.00 | Low | View details for HC Wainwright rating of Vera Therapeutics (NASDAQ:VERA) on 5/5/2025 |
NPKI NPK International | $8.27
-1.8% | 5/5/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $12.00 -> $12.00 | High | View details for HC Wainwright rating of NPK International (NYSE:NPKI) on 5/5/2025 |
INTZ Intrusion | $2.18
+1.9% | 5/5/2025 | Target Raised by | HC Wainwright | Analyst Scott Buck | Neutral -> Neutral | $1.00 -> $1.50 | Medium | View details for HC Wainwright rating of Intrusion (NASDAQ:INTZ) on 5/5/2025 |
PRLD Prelude Therapeutics | $1.09
+5.3% | 5/5/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $5.00 -> $5.00 | High | View details for HC Wainwright rating of Prelude Therapeutics (NASDAQ:PRLD) on 5/5/2025 |
ORIC ORIC Pharmaceuticals | $9.49
+1.8% | 5/5/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Buy | $21.00 -> $21.00 | Low | View details for HC Wainwright rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 5/5/2025 |
RGEN Repligen | $130.63
+1.8% | 5/5/2025 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $180.00 -> $180.00 | Low | View details for HC Wainwright rating of Repligen (NASDAQ:RGEN) on 5/5/2025 |
TRML Tourmaline Bio | $18.76
-2.7% | 5/5/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $50.00 -> $50.00 | Medium | View details for HC Wainwright rating of Tourmaline Bio (NASDAQ:TRML) on 5/5/2025 |
OKYO OKYO Pharma | $2.07
+8.7% | 5/5/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $7.00 -> $7.00 | High | View details for HC Wainwright rating of OKYO Pharma (NASDAQ:OKYO) on 5/5/2025 |
DBVT DBV Technologies | $9.03
-1.2% | 5/5/2025 | Target Raised by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $7.00 -> $16.00 | High | View details for HC Wainwright rating of DBV Technologies (NASDAQ:DBVT) on 5/5/2025 |
CDNA CareDx | $19.40
-0.6% | 5/5/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Neutral -> Neutral | $25.00 -> $25.00 | Medium | View details for HC Wainwright rating of CareDx (NASDAQ:CDNA) on 5/5/2025 |
UTHR United Therapeutics | $326.29
+0.1% | 5/5/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $425.00 -> $425.00 | Low | View details for HC Wainwright rating of United Therapeutics (NASDAQ:UTHR) on 5/5/2025 |
ARVN Arvinas | $7.53
| 5/2/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $81.00 -> $24.00 | High | View details for HC Wainwright rating of Arvinas (NASDAQ:ARVN) on 5/2/2025 |
BIIB Biogen | $133.88
+0.6% | 5/2/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $241.00 -> $187.00 | Medium | View details for HC Wainwright rating of Biogen (NASDAQ:BIIB) on 5/2/2025 |
XFOR X4 Pharmaceuticals | $4.29
-0.2% | 5/2/2025 | Target Raised by | HC Wainwright | Analyst Swayampakula Ramakanth | Buy -> Buy | $1.50 -> $7.00 | Medium | View details for HC Wainwright rating of X4 Pharmaceuticals (NASDAQ:XFOR) on 5/2/2025 |
PHAT Phathom Pharmaceuticals | $8.34
-6.5% | 5/2/2025 | Target Lowered by | HC Wainwright | Analyst Matthew Caufield | Buy -> Buy | $28.00 -> $20.00 | High | View details for HC Wainwright rating of Phathom Pharmaceuticals (NASDAQ:PHAT) on 5/2/2025 |
BLCO Bausch + Lomb | $11.87
+1.5% | 5/2/2025 | Target Lowered by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $20.00 -> $15.00 | Medium | View details for HC Wainwright rating of Bausch + Lomb (NYSE:BLCO) on 5/2/2025 |
BPMC Blueprint Medicines | $127.72
-0.1% | 5/2/2025 | Reiterated by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $135.00 -> $135.00 | High | View details for HC Wainwright rating of Blueprint Medicines (NASDAQ:BPMC) on 5/2/2025 |
IONS Ionis Pharmaceuticals | $36.38
+3.1% | 5/1/2025 | Target Raised by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $45.00 -> $50.00 | Low | View details for HC Wainwright rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 5/1/2025 |
ACIU AC Immune | $2.07
+1.7% | 5/1/2025 | Target Lowered by | HC Wainwright | Analyst Andrew Fein | Buy -> Buy | $16.00 -> $12.00 | Low | View details for HC Wainwright rating of AC Immune (NASDAQ:ACIU) on 5/1/2025 |
VGZ Vista Gold | $1.00
+3.7% | 5/1/2025 | Reiterated by | HC Wainwright | Analyst Heiko Ihle | Buy -> Buy | $2.75 -> $2.75 | High | View details for HC Wainwright rating of Vista Gold (NYSE:VGZ) on 5/1/2025 |
PRAX Praxis Precision Medicines | $44.03
-1.2% | 5/1/2025 | Reiterated by | HC Wainwright | Analyst Douglas Tsao | Buy -> Buy | $105.00 -> $105.00 | Medium | View details for HC Wainwright rating of Praxis Precision Medicines (NASDAQ:PRAX) on 5/1/2025 |
IMUX Immunic | $0.83
+4.6% | 5/1/2025 | Reiterated by | HC Wainwright | Analyst M. Caufield | Buy -> Buy | $10.00 -> $10.00 | High | View details for HC Wainwright rating of Immunic (NASDAQ:IMUX) on 5/1/2025 |
SWTX SpringWorks Therapeutics | $46.73
-0.2% | 4/30/2025 | Reiterated by | HC Wainwright | Analyst Robert Burns | Buy -> Neutral | $74.00 -> $47.00 | Low | View details for HC Wainwright rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 4/30/2025 |
JOBY Joby Aviation | $9.00
+10.8% | 4/30/2025 | Reiterated by | HC Wainwright | Analyst Amit Dayal | Buy -> Buy | $9.00 -> $9.00 | Medium | View details for HC Wainwright rating of Joby Aviation (NYSE:JOBY) on 4/30/2025 |
AEYE AudioEye | $12.44
-1.9% | 4/30/2025 | Reiterated by | HC Wainwright | Analyst Scott Buck | Buy -> Buy | $22.00 -> $22.00 | High | View details for HC Wainwright rating of AudioEye (NASDAQ:AEYE) on 4/30/2025 |
ALMS Alumis | $3.44
-4.3% | 4/30/2025 | Reiterated by | HC Wainwright | Analyst Mitchell Kapoor | Buy -> Buy | $14.00 -> $14.00 | Medium | View details for HC Wainwright rating of Alumis (NASDAQ:ALMS) on 4/30/2025 |
FHTX Foghorn Therapeutics | $4.36
-2.2% | 4/30/2025 | Reiterated by | HC Wainwright | Analyst Andres Maldonado | Buy -> Buy | $13.00 -> $13.00 | High | View details for HC Wainwright rating of Foghorn Therapeutics (NASDAQ:FHTX) on 4/30/2025 |
ERAS Erasca | $1.56
-2.8% | 4/30/2025 | Reiterated by | HC Wainwright | Analyst Andres Maldonado | Buy -> Buy | $6.00 -> $6.00 | Low | View details for HC Wainwright rating of Erasca (NASDAQ:ERAS) on 4/30/2025 |
PVLA Palvella Therapeutics | $26.15
+3.0% | 4/30/2025 | Reiterated by | HC Wainwright | Analyst A. Fein | Buy -> Buy | $38.00 -> $38.00 | High | View details for HC Wainwright rating of Palvella Therapeutics (NASDAQ:PVLA) on 4/30/2025 |
LFMD LifeMD | $12.17
-4.3% | 4/30/2025 | Reiterated by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $14.00 -> $14.00 | High | View details for HC Wainwright rating of LifeMD (NASDAQ:LFMD) on 4/30/2025 |
ZYXI Zynex | $2.19
+0.2% | 4/30/2025 | Target Lowered by | HC Wainwright | Analyst Yi Chen | Buy -> Buy | $15.00 -> $8.00 | High | View details for HC Wainwright rating of Zynex (NASDAQ:ZYXI) on 4/30/2025 |
NVCT Nuvectis Pharma | $8.56
-3.3% | 4/30/2025 | Reiterated by | HC Wainwright | Analyst Joseph Pantginis | Buy -> Buy | $11.00 -> $15.00 | Low | View details for HC Wainwright rating of Nuvectis Pharma (NASDAQ:NVCT) on 4/30/2025 |
AGEN Agenus | $5.68
-4.6% | 4/30/2025 | Reiterated by | HC Wainwright | Analyst Emily Bodnar | Neutral -> Neutral | | Medium | View details for HC Wainwright rating of Agenus (NASDAQ:AGEN) on 4/30/2025 |
ABEO Abeona Therapeutics | $6.65
-1.3% | 4/30/2025 | Target Raised by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $15.00 -> $20.00 | High | View details for HC Wainwright rating of Abeona Therapeutics (NASDAQ:ABEO) on 4/30/2025 |
VRNA Verona Pharma | $84.03
-0.4% | 4/30/2025 | Target Raised by | HC Wainwright | Analyst Raghuram Selvaraju | Buy -> Buy | $75.00 -> $85.00 | Low | View details for HC Wainwright rating of Verona Pharma (NASDAQ:VRNA) on 4/30/2025 |
CECO CECO Environmental | $26.44
+1.0% | 4/30/2025 | Upgraded by | HC Wainwright | Analyst A. Dayal | Neutral -> Buy | $33.00 | High | View details for HC Wainwright rating of CECO Environmental (NASDAQ:CECO) on 4/30/2025 |
